本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Apellis Pharmaceuticals Inc.

19.91
+0.47002.42%
盤後20.300.3900+1.96%16:47 EDT
成交量:194.89萬
成交額:3,915.42萬
市值:25.02億
市盈率:-11.08
高:20.59
開:19.58
低:19.25
收:19.44
資料載入中...
2024/01/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/22

重要事件披露

Form 8-K - Current report
2024/01/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities